Skip to main content
Study: PCSK9 inhibitors may reduce atherosclerotic plaque
9/7/2017

PCSK9 inhibitors may reduce atherosclerotic plaque according to a study presented at the European Society of Cardiology Congress. Researchers found that PCSK9 inhibitors can create "an anti-inflammatory state which may directly influence atherosclerosis and cardiovascular disease," said lead author Johan Frostegard.

Full Story: